Pluristyx
Business Services · Washington, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
201 Elliott Ave W, Seattle, Washington, ...Website
www.pluristyx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Pluristyx
Pluristyx specializes in providing cell therapy solutions, particularly focusing on the manufacturing and development of custom stem cell products, including induced pluripotent stem cells (iPSCs). The company offers a comprehensive range of services, including gene editing, GMP manufacturing, and end-to-end support throughout the product development lifecycle. Their innovative technologies and scientific expertise enable clients to accelerate the commercialization of cellular therapies. Pluristyx aims to simplify the stem cell therapy development process for clients in the biotechnology and pharmaceutical sectors.Explore more
Pluristyx Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Pluristyx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check if Pluristyx has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Pluristyx launches new products
Check out if Pluristyx is spiking on competitors!
Pluristyx, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Pluristyx had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Pluristyx
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Pluristyx recently announced quarterly report
Funding: Get notified immidiatlly once Pluristyx has new funding data
Recommended Actions
Reach out to Masked Content who joined Pluristyx as Masked Content
Find 2 more new buyers
Compare Similar Companies to Pluristyx
Compare insights from companies similar to Pluristyx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Pluristyx is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Pluristyx is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Pluristyx.
Pluristyx financials insights
Gather financial insights about Pluristyx, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Other Financing Round
$2M
2026
Private Equity
$9.8M
Pluristyx Tech Stack
A closer look at the technologies used by Pluristyx
Most Recent Scoops
Funding
Funding
Project
Product Management, Intellectual Property, Legal Affairs
Project
Research & Development, Intellectual Property, Legal Affairs, Medical Research, Healthcare Technology
Product Launch
Product Launch, Research & Development, Medical Research, Healthcare Technology
Partnership
Partnership, Product Development, Intellectual Property, Legal Affairs, Pharmaceuticals
Pluristyx News & Media
Pluristyx Inc. Secures Initial Close of Series A Priced Round with Multinational Fortune 500 Company; Round to Remain Open for Syndicate Partners Until September 2nd
Pluristyx secures a Series A priced round initial close led by a multinational Fortune 500 company to accelerate growth and expand its stem cell platform.Pluristyx Announces Patent Allowance of Next Generation Synthetic mRNA Technology in Japan, Solidifying Global iPSC Reprogramming Leadership
Pluristyx issued Japan patent allowance for next-gen synthetic mRNA, accelerating non-viral, footprint-free iPSC generation for regenerative medicinePluristyx and Qkine Announce a Reciprocal Distribution Agreement in Support of Optimized Growth Factor Differentiation of Induced Pluripotent Stem Cell (iPSC)
Pluristyx and Qkine partner on a distribution agreement to support optimized growth factor differentiation of induced pluripotent stem cells (iPSCs)Pluristyx Extends Patent Portfolio in Universal Cell Therapy with New U.S. Patent for iACT Stealth™ Technology
Pluristyx announces a new U.S. patent for iACT Stealth™ technology, enabling "cloaking" of cells to treat autoimmune diseases without immune suppression.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Pluristyx
Sign Up For FreeTo access detailed company insights
Pluristyx specializes in providing cell therapy solutions, particularly focusing on the manufacturing and development of custom stem cell products, including induced pluripotent stem cells (iPSCs). The company offers a comprehensive range of services, including gene editing, GMP manufacturing, and end-to-end support throughout the product developme... Read More
